Cholangiocarcinoma: Current Knowledge and New Developments

Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is more common in Asia, its incidence in Europe and North America has significantly increased in recent decades. The prognosis of CCA is dismal. Surgery is the only potentially curative treatment, but the majority of...

Full description

Saved in:
Bibliographic Details
Published in:Gut and liver 2017, 11(1), , pp.13-26
Main Author: Blechacz, Boris
Format: Article
Language:English
Subjects:
Asia - epidemiology
bile duct
Bile Duct Neoplasms - diagnosis
Bile Duct Neoplasms - epidemiology
Bile Duct Neoplasms - pathology
Bile Duct Neoplasms - therapy
cancer
Caroli Disease - epidemiology
Chemoradiotherapy
cholangiocarcinoma
Cholangiocarcinoma - diagnosis
Cholangiocarcinoma - epidemiology
Cholangiocarcinoma - pathology
Cholangiocarcinoma - therapy
Cholangitis, Sclerosing - epidemiology
Choledochal Cyst - epidemiology
Diabetes Mellitus - epidemiology
Hepatectomy
Hepatitis B - epidemiology
Hepatitis C - epidemiology
hepatobiliary
Humans
Klatskin Tumor - diagnosis
Klatskin Tumor - epidemiology
Klatskin Tumor - pathology
Klatskin Tumor - therapy
Liver Cirrhosis - epidemiology
Liver Diseases, Parasitic - epidemiology
Liver Transplantation
Neoadjuvant Therapy
neoplasia
Neoplasm Staging
Obesity - epidemiology
Prognosis
Review
Risk Factors
내과학
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cholangiocarcinoma (CCA) is the second most common primary malignancy. Although it is more common in Asia, its incidence in Europe and North America has significantly increased in recent decades. The prognosis of CCA is dismal. Surgery is the only potentially curative treatment, but the majority of patients present with advanced stage disease, and recurrence after resection is common. Over the last two decades, our understanding of the molecular biology of this malignancy has increased tremendously, diagnostic techniques have evolved, and novel therapeutic approaches have been established. This review discusses the changing epidemiologic trends and provides an overview of newly identified etiologic risk factors for CCA. Furthermore, the molecular pathogenesis is discussed as well as the influence of etiology and biliary location on the mutational landscape of CCA. This review provides an overview of the diagnostic evaluation of CCA and its staging systems. Finally, new therapeutic options are critically reviewed, and future therapeutic strategies discussed.
ISSN:1976-2283
2005-1212
DOI:10.5009/gnl15568